Advertisement

Immunogen Preparation and Immunization Procedures for Rats and Mice

  • Mark Page
  • Robin Thorpe
Protocol
  • 231 Downloads
Part of the Springer Protocols Handbooks book series (SPH)

Abstract

A high-titer antibody response usually requires use of an adjuvant for the first (priming) immunization. For most purposes, the immunogen is prepared by emulsification in a mineral oil containing heat-killed mycobacterium (Freund’s complete adjuvant/3-FCA). The emulsion ensures that the antigen is released slowly into the animal’s circulation, and the bacteria stimulate the animal’s T-helper cell arm of the immune system. Further booster (secondary) immunizations are almost always necessary for production of high antibody levels, and these are given either in phosphatebuffered saline (PBS) or as an oil emulsion (bacteria are not normally included in the boosting injections; a suitable oil adjuvant is Freund’s incomplete adjuvant/3-FIA). A large number of alternative adjuvants are available, but FCA/FIA (for priming and boosting respectively) usually produces maximal immune responses. However, FCA in particular can produce adverse effects in some cases and is not normally recommended for use in humans or primates Alum adjuvants are often chosen as an alternative and can be used in humans. Immunization with substances with molecular weights <3000 (such as peptides) are not normally immunogenic and will require conjugation to a carrier protein (see ref. 1 and  Chapters 117 119), such as purified protein derivative (PPD) or keyhole limpet hemocyanin (KLH).

Keywords

Purify Protein Derivative Keyhole Limpet Hemocyanin Glass Syringe High Antibody Level Immunization Procedure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Reference

  1. 1.
    Thorpe, R. (1994) Producing antibodies, in Immunochemistry Labfax (Kerr, M. A. and Thorpe, R., eds.), Bios Scientific, Oxford, UK, pp. 63–81.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2002

Authors and Affiliations

  • Mark Page
    • 1
  • Robin Thorpe
    • 2
  1. 1.Apovia Inc.San Diego
  2. 2.Division of ImmunobiologyNational Institute for Biological Standards and ControlPotters BarUK

Personalised recommendations